ELV: Elevance Health, Inc.
About
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Current Value
$396.141 Year Return
Current Value
$396.141 Year Return
Key Details
Market Cap
$91.42B
P/E Ratio
14.37
1Y Stock Return
-16.23%
1Y Revenue Growth
3.20%
Dividend Yield
1.26%
Price to Book
2.1
Strategies that include ELV
Stock's related to ELV
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CNC | 70.79% | $29.19B | -21.56% | 0.00% |
| MOH | 57.79% | $16.16B | -21.56% | 0.00% |
| UNH | 50.08% | $531.00B | +6.93% | 1.37% |
| MAN | 40.72% | $2.83B | -19.82% | 5.00% |
| BMI | 36.95% | $6.21B | +43.25% | 0.55% |
| CVS | 36.32% | $70.18B | -18.08% | 4.72% |
| KFRC | 33.73% | $1.10B | -8.71% | 0.66% |
| SAM | 33.12% | $3.58B | -7.64% | 0.00% |
| MMC | 32.72% | $108.41B | +10.89% | 1.37% |
| SR | 32.60% | $3.92B | +13.67% | 4.42% |
| CSX | 32.45% | $66.72B | +7.29% | 1.36% |
| CRVL | 31.85% | $6.14B | +68.42% | 0.00% |
| MSEX | 31.51% | $1.18B | +2.56% | 1.99% |
| HUM | 31.02% | $33.45B | -45.22% | 1.25% |
| KMPR | 30.81% | $4.52B | +69.87% | 1.75% |
| ITW | 30.72% | $78.69B | +10.19% | 2.13% |
| SW | 30.63% | $13.78B | +15.02% | 1.14% |
| HIG | 30.50% | $33.87B | +51.09% | 1.60% |
| JBHT | 30.49% | $18.17B | -0.08% | 0.95% |
| HOLX | 30.18% | $18.25B | +9.26% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TNK | 0.01% | $1.48B | -12.01% | 2.31% |
| MPAA | 0.02% | $134.99M | -29.46% | 0.00% |
| TMCI | 0.02% | $483.43M | -8.71% | 0.00% |
| FSLR | 0.05% | $20.06B | +18.13% | 0.00% |
| RPTX | -0.06% | $122.43M | -39.50% | 0.00% |
| SMCI | -0.06% | $16.55B | -2.47% | 0.00% |
| GTLB | -0.06% | $9.77B | +31.98% | 0.00% |
| TME | -0.09% | $7.80B | +28.31% | 1.22% |
| KRYS | 0.10% | $5.12B | +75.65% | 0.00% |
| SMR | 0.14% | $2.73B | +989.52% | 0.00% |
| TDW | -0.15% | $2.65B | -10.30% | 0.00% |
| NLOP | -0.15% | $458.04M | +94.60% | 0.00% |
| CORZ | -0.19% | $4.60B | +3,201.26% | 0.00% |
| OOMA | -0.19% | $365.28M | +16.00% | 0.00% |
| MRVL | -0.20% | $77.39B | +63.39% | 0.27% |
| MUX | -0.21% | $458.33M | +14.70% | 0.00% |
| HIMS | -0.23% | $5.14B | +210.42% | 0.00% |
| TKO | 0.24% | $10.62B | +67.14% | 0.00% |
| PLCE | 0.25% | $194.34M | -20.91% | 0.00% |
| NFE | -0.29% | $2.29B | -74.75% | 3.32% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AMED | -13.58% | $2.95B | -3.95% | 0.00% |
| PRPO | -12.76% | $9.10M | -13.65% | 0.00% |
| HUSA | -12.26% | $16.69M | -11.56% | 0.00% |
| NTZ | -10.93% | $47.64M | -30.94% | 0.00% |
| BTCT | -10.81% | $42.61M | +353.33% | 0.00% |
| TLPH | -9.53% | $11.41M | +9.85% | 0.00% |
| GRVY | -9.41% | $466.13M | -4.24% | 0.00% |
| DAO | -9.09% | $159.28M | +25.62% | 0.00% |
| BVN | -8.89% | $3.16B | +37.49% | 0.00% |
| UUU | -8.77% | $4.97M | -41.89% | 0.00% |
| CBOE | -7.99% | $21.46B | +15.84% | 1.11% |
| APRE | -7.88% | $16.41M | -19.47% | 0.00% |
| FLXS | -7.73% | $301.86M | +215.00% | 1.02% |
| BYRN | -7.40% | $479.70M | +295.19% | 0.00% |
| OWL | -7.20% | $13.30B | +72.82% | 2.88% |
| RTO | -7.19% | $13.07B | -10.21% | 2.25% |
| FRO | -7.12% | $4.56B | -7.37% | 9.36% |
| PLG | -7.08% | $173.19M | +67.33% | 0.00% |
| BASE | -7.03% | $1.04B | +8.03% | 0.00% |
| MNSO | -6.56% | $5.45B | -28.63% | 1.56% |
ETF's related to ELV
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IHF | 74.24% | $703.90M | 0.4% |
| XLV | 48.73% | $38.41B | 0.09% |
| VHT | 47.69% | $17.06B | 0.1% |
| FHLC | 47.14% | $2.73B | 0.084% |
| IYH | 46.70% | $3.19B | 0.39% |
| IXJ | 43.65% | $3.89B | 0.41% |
| VFLO | 42.05% | $1.35B | 0.39% |
| RWL | 41.60% | $4.09B | 0.39% |
| RSPH | 41.17% | $885.96M | 0.4% |
| USMV | 40.29% | $23.89B | 0.15% |
| FXH | 39.95% | $1.15B | 0.62% |
| VOOV | 38.83% | $5.36B | 0.1% |
| IVE | 38.68% | $36.17B | 0.18% |
| FVD | 38.67% | $9.70B | 0.6% |
| MGV | 38.60% | $8.48B | 0.07% |
| IWX | 38.55% | $2.42B | 0.2% |
| SPYV | 38.48% | $24.94B | 0.04% |
| FTCS | 38.42% | $8.97B | 0.54% |
| TDVG | 38.24% | $841.99M | 0.5% |
| DSTL | 38.21% | $2.02B | 0.39% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BCI | 0.15% | $1.20B | 0.26% |
| SPIP | 0.16% | $858.31M | 0.12% |
| AGGH | 0.26% | $253.02M | 0.33% |
| STPZ | -0.34% | $483.31M | 0.2% |
| IBTH | -0.37% | $1.08B | 0.07% |
| CXSE | 0.38% | $406.30M | 0.32% |
| YEAR | 0.39% | $1.13B | 0.25% |
| JBBB | -0.42% | $1.26B | 0.49% |
| KRBN | 0.44% | $242.47M | 0.85% |
| STIP | -0.48% | $8.74B | 0.03% |
| SHYD | -0.52% | $311.50M | 0.35% |
| CHIQ | 0.52% | $229.05M | 0.65% |
| UTWO | -0.58% | $447.63M | 0.15% |
| BCD | -0.63% | $245.02M | 0.3% |
| CMDY | -0.67% | $279.14M | 0.28% |
| AGZ | -0.74% | $708.37M | 0.2% |
| KWEB | 0.87% | $5.94B | 0.7% |
| MUST | -1.00% | $410.00M | 0.23% |
| GCC | -1.03% | $133.23M | 0.55% |
| SMMU | 1.10% | $624.12M | 0.35% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TPMN | -18.34% | $40.60M | 0.65% |
| VIXY | -14.72% | $195.31M | 0.85% |
| TAIL | -12.10% | $67.98M | 0.59% |
| CLOI | -9.53% | $715.40M | 0.4% |
| PREF | -8.84% | $999.92M | 0.55% |
| PDBC | -7.96% | $4.40B | 0.59% |
| COMT | -7.82% | $829.06M | 0.48% |
| IBTE | -7.79% | $1.70B | 0.07% |
| GSG | -7.42% | $914.42M | 0.75% |
| DBO | -7.36% | $217.57M | 0.77% |
| FLOT | -7.22% | $7.31B | 0.15% |
| DBC | -7.03% | $1.39B | 0.87% |
| IVOL | -6.86% | $548.70M | 1.02% |
| JUCY | -6.77% | $324.29M | 0.6% |
| USDU | -6.75% | $201.97M | 0.5% |
| HIGH | -6.75% | $302.78M | 0.51% |
| DBE | -6.64% | $50.13M | 0.77% |
| KCCA | -6.45% | $220.51M | 0.87% |
| BTAL | -6.44% | $388.04M | 1.43% |
| IBTF | -6.13% | $2.05B | 0.07% |
News
MarketWatch
Elevance Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains
MarketWatch
This Winning Fund Bought Nvidia on a Contrarian Bet. What It’s Buying Now.
MarketWatch
Elevance Health Inc. stock outperforms competitors despite losses on the day
Yahoo
Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Elevance Health (ELV) to $483 from $495 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving break
MarketWatch
Elevance Health Inc. stock rises Monday, still underperforms market
SeekingAlpha
Clover Healthâs 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Find out why Iâm reiterating my buy rating for CLOV stock.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.